A Single Daily Ultra Low-Dose of Oral Acyclovir Is Sufficient to Prevent the Occurrence of Herpes Zoster Post Hematopoietic Stem Cell Transplantation: Interim Results of a Prospective Randomized Trial

Authors :: Aqeela Al Lawati
David Dennison
Shyam S. Ganguly
Khalil Al Farsi
Salam Al Kindi
Abdulla Balkhair
Revathi Raj
Sharat Damodar
Intisar Al Riyami
Zahra Al Harthy
Yusra Al Habsi
Iman Maktoom Al Manthari
Abdulhakeem Al Rawas
Murtadha Al-Khabori
Arwa Z. Al Riyami
Alok Srivastava
Mohammed Al Huneini
Source :: Biology of Blood and Marrow Transplantation. (2):S261-S262
Publisher :: Published by Elsevier Inc.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
Ultra low dose
business.industry
medicine.medical_treatment
Hematology
Hematopoietic stem cell transplantation
Surgery
law.invention
Randomized controlled trial
law
Internal medicine
Interim
medicine
business

Full Text Access

Tools